Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision labels updated: Revision v3.4.2 added and Revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria', along with capitalization changes to 'No FEAR Act Data'. The site revision was updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed; this is a minor technical update with no user-facing impact. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedLocations section updated with numerous new sites across multiple US states and countries, and several sites removed. Revision: v3.3.3.SummaryDifference0.8%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.